Company / Operating Cash Flow
uniQure N.V. Operating Cash Flow History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$182.7M
FY2024
5-year range
-$182.7M / $288.0M
FY2020-FY2024
Trend
-25.2%
vs FY2023
Sector context
#165 of 216
Health Care
What the data says
uniQure N.V.'s operating cash flow of -$183M is lower than 76% of companies in the Health Care sector (FY2024). Operating Cash Flow has declined for 3 consecutive years, from $288M in FY2021 to -$183M in FY2024.
Based on SEC 10-K filings.
-$183M in FY2024.
Declined from -$145M to -$183M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 216This company -$182.7M Sector average $658.7M
▼
-127.7% below sector average
Key checks
Key Insights
- uniQure N.V.'s operating cash flow has declined for 3 consecutive years.
- In FY2024, operating cash flow decreased 25.2% year-over-year.
- Ranks #165 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$182.7M | -25.2% |
| FY2023 | -$145.9M | -0.6% |
| FY2022 | -$145.1M | -150.4% |
| FY2021 | $288.0M | +313.6% |
| FY2020 | -$134.8M | -36.6% |
| FY2019 | -$98.7M | -29.8% |
| FY2018 | -$76.0M | -18.3% |
| FY2017 | -$64.3M | +11.0% |
| FY2016 | -$72.2M | -1066.6% |
| FY2015 | $7.5M | +120.3% |
As of FY2024 · SEC Form 10-K · Last checked Jul 3, 2026